100 W. 33rd Street. New York, NY 10001, USA
Dana Maiman, President and CEO
Dana Maiman (President and CEO)
Rich Levy (Chief Creative Officer)
Mike Guarino (Chief Strategy Officer)
With more than 30 years of experience marketing to healthcare professionals, patients and consumers, FCB Health produces work that is both strategically relevant and creatively compelling. The agency provides its clients with multichannel capabilities, including payer strategy and marketing, professional education, video production, strategic planning and media services. FCB Health’s high-energy, diverse culture and global network have enabled it to strengthen its relationships with an extensive client roster, including Abbvie, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, J&J, Lilly, Novartis, Teva and Thermo Fisher. It was named “Agency of the Year” by Medical Advertising News in 2006 and 2009 and by Medical Marketing & Media in 2007 and 2010. For the last four years, 2010, 2011, 2012 and 2013, it was named Most Creative Agency by Medical Advertising News. FCB Health is a unit of Draftfcb, itself a member of the Interpublic Group (NYSE: IPG). Under its network umbrella, FCB Health has other separate full-service, multichannel healthcare agencies, including AREA 23 and NeON, as well as units focusing specifically on managed markets and medical education.
FCB Health’s operating philosophy – the 6.5 Seconds That Matter – makes us uniquely suited to serve the needs of your brand because it focuses on inspiring the deepest possible connection with your customers.
6.5 Seconds That Matter recognizes that in today’s world of information overload, marketers have a limited window to grab consumers’ attention, to persuade them to “lean in” and engage with a brand. That window of time to spark imagination and claim attention is 6.5 seconds on average. When we create communications, we have no time to waste to grab the attention of the customer: that is Real-Time Marketing.
Amplifying the 6.5 Seconds That Matter philosophy drives every aspect of our structure, culture, and process. We all work with a common focus to bring ideas to life that inspire consumers to engage with our clients’ brands, regardless of media channel. This relentless focus favorably positions FCB Health to change the customer decision-making process in favor of our client’s brands in three key areas: HCP attitudes/affinity, brand metrics, and, most importantly, sales.
- Acorda Therapeutics
- Biogen Idec
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Cubist Pharmaceuticals
- Daiichi Sankyo
- Iroko Pharmaceuticals
- Lung LLC
- Nestle Health Science
- Thermo Scientific
- Vivus Inc.